Literature DB >> 28083415

Returns on Research Funded Under the NIHR Health Technology Assessment (HTA) Programme: Economic Analysis and Case Studies.

Susan Guthrie, Marco Hafner, Teresa Bienkowska-Gibbs, Steven Wooding.   

Abstract

The Department of Health (England) requested that RAND Europe conduct an economic analysis of the impact of the HTA Programme. This article describes the results of that work, which consisted of analysis of the potential economic benefits of a sample of HTA funded studies and comparison to programme costs, supplemented by a set of short case studies exploring the impacts of the HTA Programme on policy and practice. Based on our analysis, if 12 per cent of the potential net benefit of implementing the findings of this sample of 10 studies for one year was realised, it would cover the cost of the HTA Programme from 1993 to 2012. Drawing on the case studies and the economic analysis, we have also made a number of observations that could help ensure that the HTA Programme maximises the likelihood of findings being adopted.

Year:  2016        PMID: 28083415      PMCID: PMC5158220     

Source DB:  PubMed          Journal:  Rand Health Q        ISSN: 2162-8254


  3 in total

1.  What decision-makers want and what they have been getting.

Authors:  Maurice McGregor
Journal:  Value Health       Date:  2006 May-Jun       Impact factor: 5.725

2.  Assessing the impact of health technology assessment.

Authors:  R Jacob; M McGregor
Journal:  Int J Technol Assess Health Care       Date:  1997       Impact factor: 2.188

3.  Assessing technology assessment. Early results of the Quebec experience.

Authors:  R Jacob; R N Battista
Journal:  Int J Technol Assess Health Care       Date:  1993       Impact factor: 2.188

  3 in total
  8 in total

1.  Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.

Authors:  Ian Roberts; Haleema Shakur-Still; Amy Aeron-Thomas; Danielle Beaumont; Antonio Belli; Amy Brenner; Madeleine Cargill; Rizwana Chaudhri; Nicolas Douglas; Lauren Frimley; Catherine Gilliam; Amber Geer; Zahra Jamal; Rashid Jooma; Raoul Mansukhani; Alec Miners; Jason Pott; Danielle Prowse; Temitayo Shokunbi; Jack Williams
Journal:  Health Technol Assess       Date:  2021-04       Impact factor: 4.014

2.  We need a NICE for global development spending.

Authors:  Kalipso Chalkidou; Anthony J Culyer; Amanda Glassman; Ryan Li
Journal:  F1000Res       Date:  2017-07-25

3.  Integrating research into clinical practice: challenges and solutions for Canada.

Authors:  François Lamontagne; Kathryn M Rowan; Gordon Guyatt
Journal:  CMAJ       Date:  2020-12-09       Impact factor: 8.262

Review 4.  What funders are doing to assess the impact of their investments in health and biomedical research.

Authors:  Rachel Abudu; Kathryn Oliver; Annette Boaz
Journal:  Health Res Policy Syst       Date:  2022-08-09

5.  What is the value of explicit priority setting for health interventions? A simulation study.

Authors:  Euan Barlow; Alec Morton; Saudamini Dabak; Sven Engels; Wanrudee Isaranuwatchai; Yot Teerawattananon; Kalipso Chalkidou
Journal:  Health Care Manag Sci       Date:  2022-05-28

6.  A longitudinal analysis of COVID-19 lockdown stringency on sleep and resting heart rate measures across 20 countries.

Authors:  Ju Lynn Ong; TeYang Lau; Mari Karsikas; Hannu Kinnunen; Michael W L Chee
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

7.  Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact.

Authors:  Robyn Millar; Alec Morton; Maria Vittoria Bufali; Sven Engels; Saudamini Vishwanath Dabak; Wanrudee Isaranuwatchai; Kalipso Chalkidou; Yot Teerawattananon
Journal:  Cost Eff Resour Alloc       Date:  2021-07-02

8.  How do organisations implement research impact assessment (RIA) principles and good practice? A narrative review and exploratory study of four international research funding and administrative organisations.

Authors:  Adam Kamenetzky; Saba Hinrichs-Krapels
Journal:  Health Res Policy Syst       Date:  2020-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.